Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Human Gene Therapy is Scopus-indexed (Q1, CiteScore 7.4), WoS SCIE. Published by SAGE Publications Ltd.
Checked against the index lists dated .
ISSN 1043-0342Verify ISSN ↗1557-7422Verify ISSN ↗
Publisher: SAGE Publications Ltd
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Genetics | 78 / 357 | 78th | Q1 |
| Molecular Medicine | 54 / 179 | 70th | Q2 |
| Molecular Biology | 127 / 414 | 69th | Q2 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1990–present, best quartile Q1, CiteScore 7.4.
Human Gene Therapy is Q1 in Genetics (rank 78 of 357), Q2 in Molecular Medicine (rank 54 of 179) and Q2 in Molecular Biology (rank 127 of 414), by CiteScore 2025.
Human Gene Therapy is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 7.4, which places it in quartile Q1 at the 78th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.282, quartile Q1, with an H-index of 167.
Human Gene Therapy is published by SAGE Publications Ltd. Its print ISSN is 1043-0342 and its online ISSN is 1557-7422.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Human Gene Therapy has an h-index of 186 and a 2-year mean of 3.78 citations per paper (OpenAlex). Its Scopus CiteScore is 7.4, quartile Q1. On 2-year citations it ranks #99 of 353 Scopus journals in Genetics.
Human Gene Therapy published 106 papers in 2025; its busiest recent year was 2020 with 179. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 92 research articles (2025–2026), authors are most often from United States (45.8%), China (13%) and Germany (11.7%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 10 retracted papers are recorded (1.6 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.